PHRT

Engineering meets Medicine: exclusive event on Precision and Regenerative Medicine – PHRT

News

Engineering meets Medicine: exclusive event on Precision and Regenerative Medicine

Join us on January 28, 2025, for an exclusive event hosted by PHRT in collaboration with the ETH Zurich, the University hospitals of Zurich, Balgrist and the Children’s Hospital Zurich and University Professor and Pamela & Paul Austin Chair in Precision & Regenerative Medicine, Molly Shoichet, Scientific Director of PRiME at The University of Toronto. This special event will feature a compelling talk by Prof. Shoichet on the transformative potential of precision and regenerative medicine. Following the lecture, an interactive roundtable discussion will bring together experts from hospitals, universities, and research institutions to explore the latest advances, challenges and future directions in precision medicine and how to collaborate on a global level. Don’t miss this opportunity to engage with experts in the field.

When:

January 28, 2025, 16:00-18:30

Where:

CAB H41 food&lab, Universitätsstrasse 6, Zürich (food&lab – Google Maps)

Program:

Part 1: Science

“Engineering meets Medicine: at the forefront of Precision & Regenerative Medicine”

by University Professor Molly Shoichet, Scientific Director of PRiME

Comments referring to the presentation from the Swiss perspective by:

  • Prof. Dr. Andreas Wicki, Experimental Oncology Lab, University Hospital Zurich
  • Prof. Dr. Didier Surdez, Head of Tumor Research, Balgrist University Hospital, Zurich

 

Part 2: Round table discussion about

“Establishing a collaborative global precision medicine ecosystem”

  • Identifying key components and stakeholders for a successful global hub.
  • Opportunities to leverage existing regional strengths to create a unified global network.
  • What would be the ideal partnership between clinics and academia?
  • Aligning objectives between academia, hospitals, and pharma for precision medicine initiatives.
  • Strategies for incentivizing cross-sector collaboration and resource-sharing.

with

  • Prof. Dr. Matthias Baumgartner, Director Research & Teaching, University Children’s Hospital Zurich
  • Prof. Dr. Molly Shoichet, Cell & Tissue Engineering, PRiME, University of Toronto
  • Akshita Vincent, Director, Strategy & Partnerships PRiME, University of Toronto
  • Prof. Dr. Bernd Wollscheid, Chairman of the PHRT Executive Committee, ETH Zurich
  • Prof. Dr. Andreas Wicki, Experimental Oncology Lab, University Hospital Zurich
  • Prof. Dr. Didier Surdez, Head of Tumor Research, Balgrist University Hospital, Zurich

 

Part 3: Apéro

 

No registration required.

 

Biography Molly Shoichet

Professor Molly Shoichet is University Professor, a distinction held by less than 2% of the faculty. She is the inaugural Pamela & Paul Austin Professor in Precision and Regenerative Medicine, and Scientific Director of Precision Medicine at the University of Toronto. Shoichet served as Ontario’s first Chief Scientist in 2018 where she worked to enhance the culture of science. Dr. Shoichet has published over 850 papers, patents and abstracts and has given over 590 lectures worldwide. She currently leads a laboratory of 30 and has graduated 270 researchers. Her research is focused on drug and cell delivery strategies in the central nervous system (brain, spinal cord, retina) and 3D hydrogel culture systems to model cancer. Dr. Shoichet co-founded four spin-off companies, is actively engaged in translational research and science outreach. Dr. Shoichet is the recipient of many prestigious distinctions and the first (and until recently the only) person to be inducted into all three of Canada’s National Academies of Science of the Royal Society of Canada, Engineering and Health Sciences. In 2018, Professor Shoichet was inducted as an Officer of the Order of Canada and in 2011, she was awarded the Order of Ontario. Dr. Shoichet was the L’Oreal-UNESCO For Women in Science Laureate for North America in 2015, elected Foreign Member of the US National Academy of Engineering in 2016, won the Killam Prize in Engineering in 2017 and elected Fellow to the Royal Society (UK) in 2019. In 2020, Dr. Shoichet was awarded the NSERC Herzberg Gold Medal (the highest award in science/engineering in Canada) and won the Margolese National Brain Disorders Prize. In 2023, Dr. Shoichet was elected Fellow of the US National Academy of Inventors. Dr. Shoichet received her SB from the Massachusetts Institute of Technology (1987) and her PhD from the University of Massachusetts, Amherst in Polymer Science and Engineering (1992).

 

 

Picture of Marina Pierer
Marina Pierer

Communication Specialist